Animal Models Core Facility
动物模型核心设施
基本信息
- 批准号:8340285
- 负责人:
- 金额:$ 29.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-05-23 至 2015-11-30
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAllelesAnimal ModelAnimalsAntineoplastic AgentsAreaBasic ScienceBiological ModelsBiotechnologyBudgetsCancer CenterCarcinogenicity TestsCellsComplexComprehensive Cancer CenterCore FacilityDevelopmentEngineeringFacultyFundingGap JunctionsGene TargetingGenetic MedicineGenetic screening methodGenetically Engineered MouseGrantGrowthHome environmentHomologous GeneHumanHuman ResourcesImageImmunocompetentIndividualInstitutesInternationalInvestmentsKnock-outLaboratory AnimalsLeadershipMalignant NeoplasmsModelingMolecular BiologyMusNatureNobel PrizeOncogene ProteinsPeer ReviewPharmacodynamicsPhasePhenotypePhysiologicalPositioning AttributePreventionProductionProtocols documentationQuality ControlReagentRecording of previous eventsReproducibilityResearchResearch InfrastructureResearch PersonnelResourcesRodentScreening procedureSpecificityStrategic PlanningSystemTechnologyTestingTherapeuticTherapy Clinical TrialsToxicologyTrainingTransgenic ModelTransgenic OrganismsTranslational ResearchUNC Lineberger Comprehensive Cancer CenterUnited States National Institutes of HealthViralWorkXenograft procedureanimal model developmentanticancer researchcancer geneticscostdesigngood laboratory practicehost neoplasm interactionimprovedmembermouse modelnovelnovel therapeuticspre-clinicalprogramsskillstooltumortumor xenograft
项目摘要
Animal Models Core Facility
We are combining two previous cores dealing with mouse cancer nnodels into a single Animal IVIodeis Core that functions to help LCCC members with all aspects of mouse-related research. Core staff assists with animal handling, xenograft tumor models, colony management, therapeutic trials, imaging studies, allele phenotyping and the design and production of genetically engineered mice (GEM). This core adds value to
the Cancer Center by enabling cost-efficient murine testing even by members who do not have significant infrastructure and expertise for animal work. The core is co-directed by Chariene Ross and Dale Cowley, with faculty co-advisors Norman Sharpless and Bernard Weissman. Dr. Sharpless and Dr. Cowley have been added to the leadership since the last cycle to add expertise in GEM models and expand core capabilities. Experimental help spans the spectrum from transgenic / knockout allele production and design to allele phenotyping, animal imaging and therapeutic testing of novel anti-cancer agents in xenograft and genetically engineered tumor models. The core has 39 users (97% use by peer reviewed members for Animal Studies). Significant growth has occurred in the animal studies component of the core during the last year with core staff operating beyond overall capacity since August 2009. We request an increased budget
of $283,591 that will represent 15% of the total Animal Models Core budget to promote expanded use.
The Animal Models Core will grow significantly during the next cycle, driven largely by increased NIH funding to UNC investigators, the 50% increase in campus animal space and a strategic plan featuring cancer genetics and preclinical therapeutics testing. The Genetic Medicine building has recently opened with space for over 40,000 additional cages. The Imaging Research Building will open in 2013 with 2,000 additional
cages for longitudinal mouse therapy and Imaging protocols. The Animal Models Core is well positioned to become the nexus for Cancer Center members exploiting the power of GEMs and xenograft tumor models for basic and translational cancer research.
动物模型核心机构
我们正在将之前两个处理小鼠癌症nodels的核心合并为一个动物IVIodeis核心,其功能是帮助LCCC成员进行小鼠相关研究的各个方面。核心工作人员协助动物处理,异种移植肿瘤模型,集落管理,治疗试验,成像研究,等位基因表型和基因工程小鼠(GEM)的设计和生产。这一核心增加了
癌症中心通过使具有成本效益的小鼠测试,即使是成员谁不具有重要的基础设施和专业知识的动物工作。核心是共同指导的夏琳罗斯和戴尔考利,与教师共同顾问诺曼夏普勒斯和伯纳德韦斯曼。自上一个周期以来,Sharpless博士和Cowley博士已加入领导层,以增加GEM模型方面的专业知识并扩大核心能力。实验帮助涵盖了从转基因/敲除等位基因生产和设计到等位基因表型分析、动物成像和异种移植和基因工程肿瘤模型中新型抗癌药物的治疗测试的范围。核心有39个用户(97%的使用者是动物研究的同行评审成员)。去年,核心的动物研究部分出现了显著增长,自2009年8月以来,核心工作人员的工作超出了总体能力。我们要求增加预算
283,591美元,占动物模型核心预算总额的15%,以促进扩大使用。
动物模型核心将在下一个周期显着增长,主要是由于NIH增加了对癌症研究人员的资助,校园动物空间增加了50%,以及一项以癌症遗传学和临床前治疗测试为特色的战略计划。遗传医学大楼最近开放了超过40,000个额外的笼子。影像研究大楼将于2013年开放,
用于纵向小鼠治疗和成像方案的笼。动物模型核心有能力成为癌症中心成员的纽带,利用GEM和异种移植肿瘤模型的力量进行基础和转化癌症研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bernard E. Weissman其他文献
Super-enhancers and efficacy of triptolide in small cell carcinoma of the ovary hypercalcemic type
超级增强子与雷公藤甲素在卵巢高钙血症型小细胞癌中的疗效
- DOI:
10.1016/j.isci.2025.111770 - 发表时间:
2025-02-21 - 期刊:
- 影响因子:4.100
- 作者:
Jessica D. Lang;William Selleck;Shawn Striker;Nicolle A. Hipschman;Rochelle Kofman;Anthony N. Karnezis;Felix K.F. Kommoss;Friedrich Kommoss;Jae Rim Wendt;Salvatore J. Facista;William P.D. Hendricks;Krystal A. Orlando;Patrick Pirrotte;Elizabeth A. Raupach;Victoria L. Zismann;Yemin Wang;David G. Huntsman;Bernard E. Weissman;Jeffrey M. Trent - 通讯作者:
Jeffrey M. Trent
Mutant Nrf2supE79Q/sup enhances the promotion and progression of a subset of oncogenic Ras keratinocytes and skin tumors
突变的NRF2SUPE79Q/SUP增强了致癌性Ras角质形成细胞和皮肤肿瘤的促进和进展
- DOI:
10.1016/j.redox.2024.103261 - 发表时间:
2024-09-01 - 期刊:
- 影响因子:11.900
- 作者:
John G. Witherspoon;Jonathan R. Hall;Dereje Jima;Hannah M. Atkins;Nathan T. Wamsley;Michael B. Major;Bernard E. Weissman;Robert C. Smart - 通讯作者:
Robert C. Smart
SNF5/INI1 Deficiency Destabilizes the SWI/SNF Complex During Malignant Rhabdoid Tumor Development
- DOI:
10.1016/j.cancergen.2014.09.007 - 发表时间:
2014-09-01 - 期刊:
- 影响因子:
- 作者:
Yasumichi Kuwahara;Darmood Wei;Shujie Song;Courtney Cannon;Donastas Sakellariou-Thompson;Michael Emanuele;Hajime Hosoi;Bernard E. Weissman - 通讯作者:
Bernard E. Weissman
Bernard E. Weissman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bernard E. Weissman', 18)}}的其他基金
Role of hsnf5/BAF47 Loss in Human Cancer Development
hsnf5/BAF47 缺失在人类癌症发展中的作用
- 批准号:
8322896 - 财政年份:2011
- 资助金额:
$ 29.15万 - 项目类别:
SWI/SNF complex loss facilitates gene silencing during NSCLC development
SWI/SNF 复合物丢失促进 NSCLC 发展过程中的基因沉默
- 批准号:
7635080 - 财政年份:2009
- 资助金额:
$ 29.15万 - 项目类别:
SWI/SNF Chromatin Remodeling Loss and Human Cancer
SWI/SNF 染色质重塑损失与人类癌症
- 批准号:
6681590 - 财政年份:2003
- 资助金额:
$ 29.15万 - 项目类别:
SWI/SNF Chromatin Remodeling Loss and Human Cancer
SWI/SNF 染色质重塑损失与人类癌症
- 批准号:
6790490 - 财政年份:2003
- 资助金额:
$ 29.15万 - 项目类别:
SWI/SNF Chromatin Remodeling Loss and Human Cancer
SWI/SNF 染色质重塑损失与人类癌症
- 批准号:
7098021 - 财政年份:2003
- 资助金额:
$ 29.15万 - 项目类别:
SWI/SNF Chromatin Remodeling Loss and Human Cancer
SWI/SNF 染色质重塑损失与人类癌症
- 批准号:
7267012 - 财政年份:2003
- 资助金额:
$ 29.15万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 29.15万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 29.15万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 29.15万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 29.15万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 29.15万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 29.15万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 29.15万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 29.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 29.15万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 29.15万 - 项目类别: